Monoclonal antibody ‘critical intervention’ for preventing infant RSV, study suggests Researchers found that nirsevimab reduced hospitalisations caused by respiratory syncytial virus in infants by more than 80%.…
Hub-and-spoke dispensing expansion set to begin in October 2025 Hub-and-spoke dispensing between different legal entities will be permitted from 1 October 2025 under draft amendments to the Human Medicines Regulations 2012.…
Smoking cessation drug could help young people quit vaping, study results suggest Researchers found that varenicline is an effective vaping cessation drug among participants aged 16–25 years who vape nicotine daily or near daily.…
Coroner writes to ICB following death of patient who took too many of their prescribed drugs The ‘Prevention of future deaths’ report, published on 16 April 2025, was issued following the death of patient who was waiting for mental health support.…
Antibiotic could help tackle drug-resistant gonorrhoea, study results suggest Researchers found that gepotidacin was as effective as the current recommended first-line therapy for gonorrhoea.…
Community pharmacy RSV expansion programme to be expanded four-fold The Department of Health and Social Care said up to 200 community pharmacy sites could be commissioned to provide the respiratory syncytial virus vaccination in 2025/2026.…
NHS England sets target to save £1bn on medicines by 2029 Board papers published in March 2025 said that using “commercial capabilities” had realised close to £500m in medicines savings in 2023/2024.…
Scottish government offers hospital pharmacists 8% pay increase over two years The proposed pay offer to NHS Agenda for Change staff amounts to an £701m investment and is promised to remain above the consumer price index inflation rate in 2025/2026 and 2026/2027.…
NHS England to assess feasibility of a national inhaler recycling scheme Health minister Karin Smyth said NHS England was “currently supporting the implementation of an inhaler recycling pilot to assess a national scheme’s feasibility and potential benefits”.…
NHS increases funding for inclisiran although uptake remains ‘slower than expected’ In a letter sent to colleagues, NHS England said it had increased the reimbursement fee for inclisiran from £50 to £60.…
